Prevalence and species distribution of Achromobacter sp. cultured from cystic fibrosis patients attending the Aarhus centre in Denmark

References

1. Lipuma JJ. The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev 2010; 23:299–323 [View Article][PubMed]
   [Google Scholar]
2. Emerson J, Mcnamara S, Buccat AM, Worrell K, Burns JL. Changes in cystic fibrosis sputum microbiology in the United States between 1995 and 2008. Pediatr Pulmonol 2010; 45:363–370 [View Article][PubMed]
   [Google Scholar]
3. Ridderberg W, Bendstrup KE, Olesen HV, Jensen-Fangel S, Nørskov-Lauritsen N. Marked increase in incidence of Achromobacter xylosoxidans infections caused by sporadic acquisition from the environment. J Cyst Fibros 2011; 10:466–469 [View Article][PubMed]
   [Google Scholar]
4. van Daele S, Verhelst R, Claeys G, Verschraegen G, Franckx H et al. Shared genotypes of Achromobacter xylosoxidans strains isolated from patients at a cystic fibrosis rehabilitation center. J Clin Microbiol 2005; 43:2998–3002 [View Article][PubMed]
   [Google Scholar]
5. Lambiase A, Catania MR, del Pezzo M, Rossano F, Terlizzi V et al. Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients. Eur J Clin Microbiol Infect Dis 2011; 30:973–980 [View Article][PubMed]
   [Google Scholar]
6. Amoureux L, Bador J, Siebor E, Taillefumier N, Fanton A et al. Epidemiology and resistance of Achromobacter xylosoxidans from cystic fibrosis patients in Dijon, Burgundy: first French data. J Cyst Fibros 2013; 12:170–176 [View Article][PubMed]
   [Google Scholar]
7. Kidd TJ, Ramsay KA, Hu H, Bye PT, Elkins MR et al. Low rates of Pseudomonas aeruginosa misidentification in isolates from cystic fibrosis patients. J Clin Microbiol 2009; 47:1503–1509 [View Article][PubMed]
   [Google Scholar]
8. Euzéby JP. List of bacterial names with standing in nomenclature: a folder available on the internet. Int J Syst Bacteriol 1997; 47:590–592 [View Article][PubMed]
   [Google Scholar]
9. Vandamme PA, Peeters C, Cnockaert M, Gomila M, Moore ER et al. Reclassification of Achromobacter spiritinus Vandamme et al. 2013 as a later heterotypic synonym of Achromobacter marplatensis Gomila et al. 2011. Int J Syst Evol Microbiol 2016; 66:1641–1644 [View Article][PubMed]
   [Google Scholar]
10. Vandamme PA, Peeters C, Inganäs E, Cnockaert M, Houf K et al. Taxonomic dissection of Achromobacter denitrificans Coenye et al. 2003 and proposal of Achromobacter agilis sp. nov., nom. rev., Achromobacter pestifer sp. nov., nom. rev., Achromobacter kerstersii sp. nov. and Achromobacter deleyi sp. nov. Int J Syst Evol Microbiol 2016; 66: [CrossRef]
    [Google Scholar]
11. Spilker T, Vandamme P, Lipuma JJ. A multilocus sequence typing scheme implies population structure and reveals several putative novel Achromobacter species. J Clin Microbiol 2012; 50:3010–3015 [View Article][PubMed]
    [Google Scholar]
12. Jolley KA, Maiden MC. BIGSdb: scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics 2010; 11:595 [View Article][PubMed]
    [Google Scholar]
13. Turabelidze D, Kotetishvili M, Kreger A, Morris JG, Sulakvelidze A. Improved pulsed-field gel electrophoresis for typing vancomycin-resistant enterococci. J Clin Microbiol 2000; 38:4242–4245[PubMed]
    [Google Scholar]
14. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33:2233–2239[PubMed]
    [Google Scholar]
15. Spilker T, Vandamme P, Lipuma JJ. Identification and distribution of Achromobacter species in cystic fibrosis. J Cyst Fibros 2013; 12:298–301 [View Article][PubMed]
    [Google Scholar]
16. Barrado L, Brañas P, Orellana MÁ, Martínez MT, García G et al. Molecular characterization of Achromobacter isolates from cystic fibrosis and non-cystic fibrosis patients in Madrid, Spain. J Clin Microbiol 2013; 51:1927–1930 [View Article][PubMed]
    [Google Scholar]
17. Coward A, Kenna DT, Perry C, Martin K, Doumith M et al. Use of nrdA gene sequence clustering to estimate the prevalence of different Achromobacter species among Cystic Fibrosis patients in the UK. J Cyst Fibros 2016; 15:479–485 [View Article][PubMed]
    [Google Scholar]
18. Amoureux L, Bador J, Bounoua Zouak F, Chapuis A, de Curraize C et al. Distribution of the species of Achromobacter in a French Cystic Fibrosis Centre and multilocus sequence typing analysis reveal the predominance of A. xylosoxidans and clonal relationships between some clinical and environmental isolates. J Cyst Fibros 2016; 15:486–494 [View Article][PubMed]
    [Google Scholar]
19. Ridderberg W, Wang M, Nørskov-Lauritsen N. Multilocus sequence analysis of isolates of Achromobacter from patients with cystic fibrosis reveals infecting species other than Achromobacter xylosoxidans. J Clin Microbiol 2012; 50:2688–2694 [View Article][PubMed]
    [Google Scholar]
20. Hansen CR, Pressler T, Ridderberg W, Johansen HK, Skov M. Achromobacter species in cystic fibrosis: cross-infection caused by indirect patient-to-patient contact. J Cyst Fibros 2013; 12:609–615 [View Article][PubMed]
    [Google Scholar]